PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Natural compound mitigates effects of methamphetamine abuse, University of Missouri researchers find

2013-11-19
(Press-News.org) Contact information: Jeff Sossamon
sossamonj@missouri.edu
573-882-3346
University of Missouri-Columbia
Natural compound mitigates effects of methamphetamine abuse, University of Missouri researchers find

COLUMBIA, Mo. – Studies have shown that resveratrol, a natural compound found in colored vegetables, fruits and especially grapes, may minimize the impact of Parkinson's disease, stroke and Alzheimer's disease in those who maintain healthy diets or who regularly take resveratrol supplements. Now, researchers at the University of Missouri have found that resveratrol may also block the effects of the highly addictive drug, methamphetamine.

Dennis Miller, associate professor in the Department of Psychological Sciences in the College of Arts & Science and an investigator with the Bond Life Sciences Center, and researchers in the Center for Translational Neuroscience at MU, study therapies for drug addiction and neurodegenerative disorders. Their research targets treatments for methamphetamine abuse and has focused on the role of the neurotransmitter dopamine in drug addiction. Dopamine levels in the brain surge after methamphetamine use; this increase is associated with the motivation to continue using the drug, despite its adverse consequences. However, with repeated methamphetamine use, dopamine neurons may degenerate causing neurological and behavioral impairments, similar to those observed in people with Parkinson's disease.

"Dopamine is critical to the development of methamphetamine addiction—the transition from using a drug because one likes or enjoys it to using the drug because one craves or compulsively uses it," Miller said. "Resveratrol has been shown to regulate these dopamine neurons and to be protective in Parkinson's disease, a disorder where dopamine neurons degenerate; therefore, we sought to determine if resveratrol could affect methamphetamine-induced changes in the brain."

Using procedures established by Parkinson's and Alzheimer's disease research, rats received resveratrol once a day for seven days in about the same concentration as a human would receive from a healthy diet. After a week of resveratrol, researchers measured how much dopamine was released by methamphetamine. Researchers found that resveratrol significantly diminished methamphetamine's ability to increase dopamine levels in the brain. Furthermore, resveratrol diminished methamphetamine's ability to increase activity in mice, a behavior that models the hyperactivity observed in people that use the stimulant.

"People are encouraged by physicians and dieticians to include resveratrol-containing products in their diet and protection against methamphetamine's harmful effects may be an added bonus," Miller said. "Additionally, there are no consistently effective treatments to help people who are dependent on methamphetamine. Our initial research suggests that resveratrol could be included in a treatment regimen for those addicted to methamphetamine and it has potential to decrease the craving and desire for the drug. Resveratrol is found in good, colorful foods, and has few side effects. We all ought to consume resveratrol for good brain health; our research suggests it may also prevent the changes in the brain that occur with the development of drug addiction."



INFORMATION:



The study "Repeated resveratrol treatment attenuates methamphetamine-induced hyperactivity and [3H]dopamine overflow in rodents," was published in Neuroscience Letters. Collaborators included Grace Y. Sun, professor of biochemistry, and Agnes Simonyi, associate research professor of biochemistry in the College of Agriculture, Food and Natural Resources, at the University of Missouri.

The Center for Translational Neuroscience is home to research teams who work together to translate neuroscience discoveries into clinical treatments for patients and highlights MU's interdisciplinary, highly collaborative culture in the area of One Health/One Medicine. Four key areas of collaborative strength that distinguish MU are collectively known as the Mizzou Advantage. The other three areas are Food for the Future, Sustainable Energy, and Media of the Future.



ELSE PRESS RELEASES FROM THIS DATE:

New models predict where E. coli strains will thrive

2013-11-19
New models predict where E. coli strains will thrive Bioengineers at the University of California, San Diego have used the genomic sequences of 55 E. coli strains to reconstruct the metabolic repertoire for each strain. Surprisingly, these reconstructions ...

UEA research reveals how farmers could mitigate nitrous oxide emissions

2013-11-19
UEA research reveals how farmers could mitigate nitrous oxide emissions Farmers may be able to help reduce emissions of the greenhouse gas nitrous oxide (N2O) by incorporating copper into crop fertilisation processes – according to new research from the University ...

Underwater 'tree rings'

2013-11-19
Underwater 'tree rings' Calcite crusts of arctic algae record 650 years of sea ice change Almost 650 years of annual change in sea-ice cover can been seen in the calcite crust growth layers of seafloor algae, says a new study from the University of Toronto Mississauga ...

Among patients with recent ACS, use of enzyme inhibitor does not reduce risk of cardiovascular event

2013-11-19
Among patients with recent ACS, use of enzyme inhibitor does not reduce risk of cardiovascular event Chicago – Stephen J. Nicholls, M.B.B.S., Ph.D., of the South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, ...

In enzyme's isoforms, hope for developing heart drugs that improve contractility, prevent SCD

2013-11-19
In enzyme's isoforms, hope for developing heart drugs that improve contractility, prevent SCD (SALT LAKE CITY)—Drugs known as PDE3 inhibitors save many lives by helping failing hearts do a better job of pumping blood. But those same medications come with ...

National study finds renal stenting does not improve outcomes for renal artery stenosis patients

2013-11-19
National study finds renal stenting does not improve outcomes for renal artery stenosis patients Rhode Island Hospital researchers play lead roles in study; will present findings at the annual meeting of the American Heart Association PROVIDENCE, R.I. – According to the findings ...

2 studies on the use of breast MRI

2013-11-19
2 studies on the use of breast MRI CHICAGO – The overall use of breast magnetic resonance imaging has increased, with the procedure most commonly used for diagnostic evaluations and screenings, according to a study published by JAMA Internal Medicine, a JAMA ...

Beta-blockers before surgery appear associated with lower risk of heart-related events

2013-11-19
Beta-blockers before surgery appear associated with lower risk of heart-related events Giving beta-blocker medication to patients with heart disease undergoing noncardiac surgery appears to be associated with a lower risk of death and major adverse cardiovascular events (MACE) ...

Poorer, rural counties have lower CPR training rates

2013-11-19
Poorer, rural counties have lower CPR training rates Cardiopulmonary resuscitation (CPR) training appears to be lower in more rural counties, those with higher proportions of black and Hispanic residents and lower household incomes, and in the South, Midwest ...

Drinking more milk as a teenager does not lower risk of hip fracture later

2013-11-19
Drinking more milk as a teenager does not lower risk of hip fracture later Drinking more milk as a teenager apparently does not lower the risk of hip fracture as an older adult and instead appears to increase that risk for men, according to a study published by ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Natural compound mitigates effects of methamphetamine abuse, University of Missouri researchers find